Dialysates for treating aids and arc and for otherwise increasin

Details Dialysates for treating aids and arc and for otherwise increasin Dialysates for treating aids and arc and for otherwise increasin

1990-01-24

1992-03-03

Lee, Lester I.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530331, 514 19, A61K 3702, C07K 506, C07K 508

Patent

active

050933213

ABSTRACT:
Purified human leukocyte dialysates are described for treatment of AIDS, ARC, and other immunodeficient conditions. The dialysates are purified by HPLC processes, and are made available in a form that is free of endotoxin and pyrogen. A dialysate designated Beta-1.11 is found by amino acid sequencing to consist essentially of endogenous Tyr-Gly. A dialysate designated Beta-1.12 is found by amino acid sequencing to consist essentially of endogenous Tyr-Gly-Gly.

REFERENCES:
patent: 4468379 (1984-08-01), Gottlieb
patent: 4699898 (1987-10-01), Gottlieb
Fulton et al. Chemical Abstracts 1980, vol. 93, Abstract No. 24259n.

Affiliated with

Also associated with

Rating

Dialysates for treating aids and arc and for otherwise increasin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dialysates for treating aids and arc and for otherwise increasin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dialysates for treating aids and arc and for otherwise increasin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-272256